Analyst Explains Why He’s Investing in This Top Biotech ETF
“But this is a subsector that’s been under the mat for quite some time. So it’s nice to see some price action there. So couple things for me.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 557,807 | $94,185,712 | 0.08% | |
| 2. | D E Shaw D. E. Shaw | 389,056 | $65,692,106 | +892% | 0.04% |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 302,307 | $51,044,505 | +1% | 0.35% |
| 4. | 156,400 | $26,408,140 | -2% | 0% | |
| 5. | 91,500 | $15,449,775 | -66% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,259,501 | $1,225,766,758 | 0.09% | |
| 2. | 5,122,689 | $864,966,099 | 0.37% | |
| 3. | 2,773,467 | $468,300,256 | 0.03% | |
| 4. | 2,429,567 | $410,232,388 | 0.2% | |
| 5. | 2,460,954 | $398,330,137 | 0.03% |